Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study

IntroductionCongestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match th...

Full description

Bibliographic Details
Main Authors: Pupalan Iyngkaran, Fahad Hanna, Sharon Andrew, John David Horowitz, Malcolm Battersby, Maximilian Pangratius De Courten
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1059735/full
_version_ 1797813379048407040
author Pupalan Iyngkaran
Pupalan Iyngkaran
Fahad Hanna
Sharon Andrew
John David Horowitz
Malcolm Battersby
Maximilian Pangratius De Courten
author_facet Pupalan Iyngkaran
Pupalan Iyngkaran
Fahad Hanna
Sharon Andrew
John David Horowitz
Malcolm Battersby
Maximilian Pangratius De Courten
author_sort Pupalan Iyngkaran
collection DOAJ
description IntroductionCongestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match the various patient needs. Chronic disease self-management (CDSM) programmes that are patient-focused, identify problems and set actionable goals that appear as a logical, cost-friendly method to navigate patient journeys. There have been challenges in standardising and implementing CHF programmes.Methods and analysisSELFMAN-HF is a prospective, observational study to evaluate the feasibility and validity of the SCRinHF tool, a one-page self-management and readmission risk prediction tool for CHF, with an established, comprehensive CDSM tool. Eligible patients will have CHF with left ventricular ejection fraction <40% and commenced sodium glucose co-transporter-2 inhibitors (SGLT2-i) within 6 months of recruitment. The primary endpoint is the 80% concordance in readmission risk predicted by the SCRinHF tool. The study will recruit >40 patients and is expected to last 18 months.Ethics and disseminationThis study has been approved by the St Vincent’s ethics committee (approval no. LRR 177/21). All participants will complete a written informed consent prior to enrolment in the study. The study results will be disseminated widely via local and international health conferences and peer-reviewed publications.
first_indexed 2024-03-13T07:52:06Z
format Article
id doaj.art-7371b48b8ba44214a12578fd8890e659
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-13T07:52:06Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-7371b48b8ba44214a12578fd8890e6592023-06-02T13:22:05ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-05-011010.3389/fmed.2023.10597351059735Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational studyPupalan Iyngkaran0Pupalan Iyngkaran1Fahad Hanna2Sharon Andrew3John David Horowitz4Malcolm Battersby5Maximilian Pangratius De Courten6Heart Failure & Cardiac Imaging, Torrens University, Melbourne, VIC, AustraliaWerribee Mercy Sub School, School of Medicine, University of Notre Dame, Werribee, VIC, AustraliaPublic Health, Torrens University Australia, Melbourne, VIC, AustraliaInstitute of Health and Sport, Victoria University, Melbourne, VIC, AustraliaBasil Hetzel Institute for Translational Health Research, University of Adelaide, Adelaide, SA, AustraliaFlinders Health and Medical Research Institute, Southern Adelaide Local Health Network Mental Health Service, College of Medicine and Public Health, Flinders University, Bedford Park, SA, AustraliaMitchell Institute, Victoria University, Melbourne, VIC, AustraliaIntroductionCongestive heart failure (CHF) causes significant morbidity and mortality. It is an epidemic, and costs are escalating. CHF is a chronic disease whose trajectory includes stable phases, periods of decompensation, and finally palliation. Health services and medical therapies must match the various patient needs. Chronic disease self-management (CDSM) programmes that are patient-focused, identify problems and set actionable goals that appear as a logical, cost-friendly method to navigate patient journeys. There have been challenges in standardising and implementing CHF programmes.Methods and analysisSELFMAN-HF is a prospective, observational study to evaluate the feasibility and validity of the SCRinHF tool, a one-page self-management and readmission risk prediction tool for CHF, with an established, comprehensive CDSM tool. Eligible patients will have CHF with left ventricular ejection fraction <40% and commenced sodium glucose co-transporter-2 inhibitors (SGLT2-i) within 6 months of recruitment. The primary endpoint is the 80% concordance in readmission risk predicted by the SCRinHF tool. The study will recruit >40 patients and is expected to last 18 months.Ethics and disseminationThis study has been approved by the St Vincent’s ethics committee (approval no. LRR 177/21). All participants will complete a written informed consent prior to enrolment in the study. The study results will be disseminated widely via local and international health conferences and peer-reviewed publications.https://www.frontiersin.org/articles/10.3389/fmed.2023.1059735/fullcongestive heart failureFlinders programmixed methods research methodologyprotocolrisk assessmentself-management
spellingShingle Pupalan Iyngkaran
Pupalan Iyngkaran
Fahad Hanna
Sharon Andrew
John David Horowitz
Malcolm Battersby
Maximilian Pangratius De Courten
Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
Frontiers in Medicine
congestive heart failure
Flinders program
mixed methods research methodology
protocol
risk assessment
self-management
title Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
title_full Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
title_fullStr Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
title_full_unstemmed Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
title_short Comparison of short and long forms of the Flinders program of chronic disease SELF-management for participants starting SGLT-2 inhibitors for congestive heart failure (SELFMAN-HF): protocol for a prospective, observational study
title_sort comparison of short and long forms of the flinders program of chronic disease self management for participants starting sglt 2 inhibitors for congestive heart failure selfman hf protocol for a prospective observational study
topic congestive heart failure
Flinders program
mixed methods research methodology
protocol
risk assessment
self-management
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1059735/full
work_keys_str_mv AT pupalaniyngkaran comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy
AT pupalaniyngkaran comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy
AT fahadhanna comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy
AT sharonandrew comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy
AT johndavidhorowitz comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy
AT malcolmbattersby comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy
AT maximilianpangratiusdecourten comparisonofshortandlongformsoftheflindersprogramofchronicdiseaseselfmanagementforparticipantsstartingsglt2inhibitorsforcongestiveheartfailureselfmanhfprotocolforaprospectiveobservationalstudy